Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-16

Clinical Trial Update: Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of Dibifree on regulation of blood sugar and HbA1c in patients with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dibifree

Snippet

Sponsor: Global Preventive Medicine Biotech Co., Ltd. | Conditions: Type II Diabetes | NA | Status: COMPLETED